Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials.

Chumsri, Saranya; Li, Zhuo; Serie, Daniel J; Norton, Nadine; Mashadi-Hossein, Afshin; Tenner, Kathleen; Brauer, Heather Ann; Warren, Sarah; Danaher, Patrick; Colon-Otero, Gerardo; Partridge, Ann H; Carey, Lisa A; Hilbers, Florentine; Van Dooren, Veerle; Holmes, Eileen; Di Cosimo, Serena; Werner, Olena; Huober, Jens Bodo; Dueck, Amylou C; Sotiriou, Christos; Saura, Cristina; Moreno-Aspitia, Alvaro; Knutson, Keith L; Perez, Edith A; Thompson, E Aubrey

Chumsri, Saranya; Li, Zhuo; Serie, Daniel J; Norton, Nadine; Mashadi-Hossein, Afshin; Tenner, Kathleen; Brauer, Heather Ann; Warren, Sarah; Danaher, Patrick; Colon-Otero, Gerardo; Partridge, Ann H; Carey, Lisa A; Hilbers, Florentine; Van Dooren, Veerle; Holmes, Eileen; Di Cosimo, Serena; Werner, Olena; Huober, Jens Bodo; Dueck, Amylou C; Sotiriou, Christos; Saura, Cristina; Moreno-Aspitia, Alvaro; Knutson, Keith L; Perez, Edith A; Thompson, E Aubrey.

Afiliación

Chumsri S; Jacoby Center for Breast Health, Mayo Clinic, Jacksonville, FL, USA. chumsri.saranya@mayo.edu.
Li Z; Department of Health and Human Services, Mayo Clinic, Jacksonville, FL, USA.
Serie DJ; Department of Health and Human Services, Mayo Clinic, Jacksonville, FL, USA.
Norton N; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
Mashadi-Hossein A; NanoString, Inc., Seattle, WA, USA.
Tenner K; Department of Health and Human Services, Mayo Clinic, Rochester, MN, USA.
Brauer HA; NanoString, Inc., Seattle, WA, USA.
Warren S; NanoString, Inc., Seattle, WA, USA.
Danaher P; NanoString, Inc., Seattle, WA, USA.
Colon-Otero G; Jacoby Center for Breast Health, Mayo Clinic, Jacksonville, FL, USA.
Partridge AH; Dana-Farber Cancer Institute, Boston, MA, USA.
Carey LA; The University of North Carolina, Chapel Hill, NC, USA.
Hilbers F; Breast International Group, Brussels, Belgium.
Van Dooren V; BrEAST Institut Jules Bordet, Brussels, Belgium.
Holmes E; The Frontier Science, Perth, UK.
Di Cosimo S; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Werner O; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Huober JB; Novartis, Basel-City, Switzerland.
Dueck AC; Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm, Ulm, Germany.
Sotiriou C; Mayo Clinic, Scottsdale, AZ, USA.
Saura C; Institut Jules Bordet, Brussels, Belgium.
Moreno-Aspitia A; Vall d'Hebrón University Hospital, Vall d'Hebron Institute of Oncology (VHIO), SOLTI Breast Cancer Research Group, Barcelona, Spain.
Knutson KL; Jacoby Center for Breast Health, Mayo Clinic, Jacksonville, FL, USA.
Perez EA; Department of Immunology, Mayo Clinic, Jacksonville, FL, USA.
Thompson EA; Jacoby Center for Breast Health, Mayo Clinic, Jacksonville, FL, USA.

NPJ Breast Cancer ; 8(1): 68, 2022 May 24.

Article en En | MEDLINE | ID: mdl-35610260

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: NPJ Breast Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google